Whitehawk Therapeutics (WHWK) Leases (2019 - 2024)
Historic Leases for Whitehawk Therapeutics (WHWK) over the last 6 years, with Q4 2024 value amounting to $787000.0.
- Whitehawk Therapeutics' Leases fell 3267.75% to $787000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $787000.0, marking a year-over-year decrease of 3267.75%. This contributed to the annual value of $787000.0 for FY2024, which is 3267.75% down from last year.
- Latest data reveals that Whitehawk Therapeutics reported Leases of $787000.0 as of Q4 2024, which was down 3267.75% from $886000.0 recorded in Q3 2024.
- Whitehawk Therapeutics' 5-year Leases high stood at $1.7 million for Q2 2022, and its period low was $9452.0 during Q2 2021.
- Moreover, its 5-year median value for Leases was $886000.0 (2024), whereas its average is $829310.9.
- Per our database at Business Quant, Whitehawk Therapeutics' Leases plummeted by 9176.04% in 2021 and then surged by 1738836.23% in 2022.
- Quarter analysis of 5 years shows Whitehawk Therapeutics' Leases stood at $89761.0 in 2020, then soared by 520.54% to $557000.0 in 2021, then skyrocketed by 173.25% to $1.5 million in 2022, then dropped by 23.19% to $1.2 million in 2023, then tumbled by 32.68% to $787000.0 in 2024.
- Its Leases was $787000.0 in Q4 2024, compared to $886000.0 in Q3 2024 and $982000.0 in Q2 2024.